GGrantIndex
Sort

46,585 grants matching heart failure

Clinical Center for Look AHEAD: Action for Health in Diabetes

$604,603
Anne L Peters · University Of Southern California · U01 · FY2008 · DK

Sirtuin 3 Inactivation and SOD2 Acetylation in Vascular Dysfunction and Hypertension

$604,597
Sergey Dikalov · Vanderbilt University Medical Center · R01 · FY2022 · HL

Sirtuin 3 Inactivation and SOD2 Acetylation in Vascular Dysfunction and Hypertension

$604,580
Sergey Dikalov · Vanderbilt University Medical Center · R01 · FY2023 · HL

DEVELOPING INNOVATIVE STROKE TRIAL DESIGNS

$604,565
Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS

Reducing risk of Anthracycline-related heart failure after childhood cancer

$604,525
Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA

Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias

$604,478
Hector H Valdivia · University Of Wisconsin-Madison · R01 · FY2024 · HL

PRIMARY ECG - MRI RISK STRATIFICATION

$604,473
Joao A C Lima · Johns Hopkins University · P20 · FY2010 · HL

Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)

$604,447
Jordana B. Cohen · University Of Pennsylvania · R01 · FY2020 · HL

TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.

$604,339
Wendy Post · Johns Hopkins University · N01 · FY2023 · HL

THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY FIELD CENTER - TASK AREA B

$604,301
Pamela Lutsey · University Of Minnesota · N01 · FY2024 · HL

Core--Heart Failure Genomics

$604,291
Gerald W. Dorn · University Of Cincinnati · P50 · FY2006 · HL

A Clinical Trial of Aspirin and Simvastatin in Pulmonary Arterial Hypertension

$604,283
Steven M Kawut · Columbia University Health Sciences · R01 · FY2007 · HL

Roles of Ischemia and mechanical dyssynchrony in optimizing CRT responses

$604,282
Lik Chuan Lee · Michigan State University · R01 · FY2017 · HL

Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies

$604,241
Dipayan Chaudhuri · University Of Utah · R01 · FY2023 · HL

The impact of wildfire smoke exposure on cardiovascular health in the western US

$604,217
Yang Liu · Emory University · R01 · FY2023 · ES

Air Pollutants and Cardiovascular Risk: Investigating Thresholds with Pooled Cohorts and Electronic Health Records

$604,215
Joel Daniel Kaufman · University Of Washington · R01 · FY2020 · ES

Affective science and smoking cessation: Real time real world assessment

$604,199
Cho Yan Lam · University Of Utah · R01 · FY2022 · CA

Acoustic Radiation Force Impulse (ARFI) Imaging of Cardiac Tissue

$604,197
Gregg E. Trahey · Duke University · R37 · FY2012 · HL

Multilevel Time-Dynamic Modeling of Hospitalization and Survival in Patients on Dialysis

$604,188
Damla Senturk · University Of California Los Angeles · R01 · FY2023 · DK

Roles of SARM1 NAD hydrolase in metabolic cardiomyopathy

$604,146
Chi Fung Lee · Oklahoma Medical Research Foundation · R01 · FY2024 · HL

Stem Cells for Dilated Cardiomyopathy

$604,129
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2015 · HL

A new molecular pathway for diabetic cardiomyopathy

$604,110
Richard N Kitsis · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · HL

CVD protection mechanisms involving ACE2/Ang-(1-7) axis

$604,105
Mohan K. Raizada · University Of Florida · R01 · FY2012 · HL

Surgery for Ischemic Mitral Regurgitation

$604,079
Mark B Ratcliffe · Northern California Institute/Res/Edu · R01 · FY2009 · HL

Development Of P2Y Receptor Ligands

$604,070
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK